Clinetic Inc., health software and technology company based in Raleigh has raised $6.4 million in equity, according to a filing with the U.S. Securities and Exchange Commission.
The Duke spinout explains that its platform embeds research data curation capabilities into standard care delivery workflows. It can be deployed for specific trials but is highly adaptive to be used for other trials or quality improvement and efficiency applications.
Its connectivity to health systems and electronic health record systems enables real-world data trials, disease surveillance, and quality improvement programs.
Its software monitors EHR data for signals in near real-time, surfaces actionable next steps, and facilitates the completion of those next steps, according to the company website.
For example, the software can identify patients who may be eligible for a study, alert a study coordinator, facilitate digital enrollment, and collect patient data without requiring an in-person visit.
It adds, “At Clinetic, we believe that technology and digitization should fundamentally change the way
health care is delivered and how clinical research is performed. At the same time, we recognize
that technology alone is not enough and that trusted change agents are critical for the
implementation of sustainable, end-to-end solutions.”
The Triangle Business Journal reports the company is hiring locally.
AgTech Vindara plants $1.9M raise
Vindara, a Durham-based agriculture technology company focused on seeds for indoor farming has raised $1.9 million in debt from 11 investors, according to an SEC filing. The company operates out of the AgTech Accelerator.
Vindara, was founded in 2018, was initally led by John Dombrosky.At the time, Dombrosky was the CEO of AgTech Accelerator, a startup accelerator focused on discovering and developing emerging agricultural technology companies.
Roger Kemble, co-founder, is now CEO. He previously held leadership roles with Syngenta Biotechnology Corp.
Vindara is the first company to deliver seeds specifically designed for use in indoor farms and the key to pushing market projections even further, removing limitations that traditional seeds impose and giving growers, retailers, and consumers even greater control over their produce.
Vindara photo.
It seeds are developed entirely via analytics, using no gene-editing or GMO methods.
According to the company, “Today’s commercial outdoor seeds are almost exactly opposed to what indoor growers need, being bred for resistance to disease and pests and designed for long storage and transportation. While necessary for outdoor conditions, this results in genetic tradeoffs that can produce a lack of flavor, color, and nutritional value.
It adds, “In essence, we’re lifting the burden imposed by today’s off-the-shelf seeds with tailor-made alternatives designed specifically for indoor use.”
